OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights
Go back to OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 286.92 +2.65 (0.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $284.27 | 52 Week High | $139.79 | |||
| Open | $285.73 | 52 Week Low | $82.07 | |||
| Day High | $290.33 | P/E | 667.26 | |||
| Day Low | $281.69 | EPS | $0.43 | |||
| Volume | 189,616 | |||||
| (NASDAQ: OABI) | Delayed: 5.04 +0.60 (13.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.44 | 52 Week High | $ | |||
| Open | $4.47 | 52 Week Low | $ | |||
| Day High | $5.43 | P/E | N/A | |||
| Day Low | $4.47 | EPS | $ | |||
| Volume | 5,084,227 | |||||
